Teleflex Incorporated (TFX)

$139.67

up-down-arrow $1.96 (1.42%)

As on 28-Aug-2026 16:00EDT

Market cap

info icon

$5,719 Mln

Revenue (TTM)

info icon

$2,601 Mln

P/E Ratio

info icon

89.1

P/B Ratio

info icon

2

Div. Yield

info icon

1 %

Teleflex (TFX) Share Price

Compare

High: Low: Return:

Max: Min: Median:

Max: Min: Median:

loading...
loading...
loading...
loading...
loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: 137.35 High: 140.57

52 Week Range

Low: 101.01 High: 145.00

Liquidityliquidity High

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    $-409 Mln

  • ROEROE information

    -0 %

  • ROCEROCE information

    -15.2 %

  • Industry P/EIndustry P/E information

    44.46

  • EV/EBITDAEV/EBITDA information

    32.5

  • Debt to EquityDebt to Equity information

    0.9

  • Book ValueBook Value information

    $--

  • EPSEPS information

    $-23.2

  • Face valueFace value information

    --

  • Shares outstandingShares outstanding information

    42,372,397

10 Years Aggregate

CFO

$4,233.25 Mln

EBITDA

$6,202.22 Mln

Net Profit

$3,024.88 Mln

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Teleflex (TFX)
14.4 6.6 7.4 7.9 -13.5 -18.5 -2.6
BSE Sensex
-8.8 0.6 1.8 -4.4 6.0 6.6 10.8
S&P Midcap 400
12.9 0.2 1.6 15.8 13.6 6.4 9.3
As on 28-Aug-2026
Company
2025
2024
2023
2022
2021
2020
2019
Teleflex (TFX)
-31.4 -28.4 -0.1 -24.0 -20.2 9.3 45.6
S&P Midcap 400
5.9 12.1 14.4 -14.5 23.2 11.8 24.1
BSE Sensex
9.1 8.1 18.7 4.4 22.0 15.8 14.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...

*All values are in ($ Mln)

loading...

*All values are in ($ Mln)

loading...

*All values are in ($ Mln)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peers

View Details
Company
Price ($) Market Cap ($ Mln) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
Teleflex (TFX)
139.7 5,718.6 2,600.6 -1,029.4 -14.6 -34.1 89.1 2.0
112.5 201,831.9 46,585.0 5,425.0 13.3 10.5 36.9 3.9
157.6 11,194.5 4,139.5 413.6 15.2 10 27.4 2.7
26.1 13,653.9 11,470.0 -1,063.0 -1.8 -17.2 -- 2.2
387.7 10,065.9 2,589.3 222.4 -6.0 3 44.4 1.4
83.0 11,502.2 3,144.9 535.5 15.1 11.5 22.5 2.5
89.5 10,197.8 13,602.0 403.0 5.3 11.9 26.1 3.2
145.1 10,065.4 3,053.5 375.3 13.7 25.6 27.2 7.0
26.7 26,879.3 17,664.0 1,114.0 10.3 9.9 21 2.0
622.2 232,034.9 46,336.0 6,978.0 18.6 13.1 33 4.3

Shareholding Pattern

View Details
loading...
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

About Teleflex (TFX)

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, Europe, the Middle East, Africa, the Asia...  Pacific, and internationally. The company offers vascular and emergency medicine products comprising Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, measurement of blood pressure, and collection of blood samples; intraosseous access systems consisting of EZ-IO intraosseous vascular access systems, and Arrow FAST1 sternal intraosseous infusion systems; and hemostatic products, including external hemostats and trauma products under the QuikClot brand. It also provides interventional products, including various coronary catheters, structural heart support devices, and peripheral intervention products platforms; GuideLiner, Turnpike, and TrapLiner catheters; MANTA vascular closure devices and Arrow OnControl powered bone biopsy systems; and coronary and peripheral medical devices, such as drug-coated balloons, stents, and balloon catheters. In addition, the company offers surgical products, including metal and polymer ligating clips using manual and automatic applier system, fascial closure surgical systems used in laparoscopic surgical procedures, percutaneous surgical systems, powered bariatric staplers, and other surgical instruments under the Weck, MiniLap, Pleur-Evac, Deknatel, KMedic, Pilling, and Titan SGS brands. It serves hospitals, healthcare providers, and medical device manufacturers. The company also sells its products online. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania. 

  • Chairman, President & CEO

    Mr. Liam J. Kelly

  • Corporate VP & President of Global Commercial

    Mr. Jay White

  • Headquarters

    Wayne, PA

  • Website

    https://www.teleflex.com

FAQs for Teleflex (TFX)

The share price of Teleflex Incorporated (TFX) is $139.67 (NYSE) as of 28-Aug-2026 16:00 EDT. Teleflex Incorporated (TFX) has given a return of -13.55% in the last 3 years.

The P/E ratio of Teleflex Incorporated (TFX) is 89.09 times as on 21-Aug-2026, a 100 premium to its peers’ median range of 44.46 times.
The P/B ratio of Teleflex Incorporated (TFX) is 1.98 times as on 21-Aug-2026, a 48 discount to its peers’ median range of 3.79 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2025
-5.96
1.73
2024
118.46
1.93
2023
33.10
2.66
2022
32.46
2.93
2021
32.09
4.15

The 52-week high and low of Teleflex Incorporated (TFX) are Rs 145.00 and Rs 101.01 as of 31-Aug-2026.

Teleflex Incorporated (TFX) has a market capitalisation of $ 5,719 Mln as on 21-Aug-2026. As per SEBI classification, it is a Mid Cap company.

Before investing in Teleflex Incorporated (TFX), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.

loading...
loading...